Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ianko Iankov
Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted Against the Urokinase Receptor
Cancer Research
Cancer Research
Oncology
Related publications
Retargeted Oncolytic Measles Strains Entering via the EGFRvIII Receptor Maintain Significant Antitumor Activity Against Gliomas With Increased Tumor Specificity
Cancer Research
Cancer Research
Oncology
High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus
Cancer Research
Cancer Research
Oncology
Oncolytic Herpes Virus Retargeted to HER-2
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Specific Elimination of CD133+ Tumor Cells With Targeted Oncolytic Measles Virus
Cancer Research
Cancer Research
Oncology
Antitumor Efficacy of 34.5ENVE: A Transcriptionally Retargeted and “Vstat120”-Expressing Oncolytic Virus
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
A Novel Oncolytic Adenovirus Targeting to Telomerase Activity in Tumor Cells With Potent
Oncogene
Cancer Research
Genetics
Molecular Biology
Measles Virus Selectively Blind to Signaling Lymphocyte Activation Molecule as a Novel Oncolytic Virus for Breast Cancer Treatment
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
639. MicroRNA-Mediated Multi-Tissue-Detargeting of Oncolytic Measles Virus
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients With Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
